Your browser does not fully support modern features. Please upgrade for a smoother experience.
Pre-Treatment Lymphocyte Count Influences ATLG Transplantation Outcomes
- Subjects: Hematology; Transplantation
- |
- Contributors:
- Alexander Nikoloudis ,
- Veronika Buxhofer-Ausch ,
- Christoph Aichinger ,
- Michaela Binder ,
- Petra Hasengruber ,
- Emine Kaynak ,
- Dagmar Wipplinger ,
- Robert Milanov ,
- Irene Strassl ,
- Olga Stiefel ,
- Sigrid Machherndl-Spandl ,
- Andreas Petzer ,
- Ansgar Weltermann ,
- Johannes Clausen
- GVHD
- ALC
- ATLG
- HSCT
Video Introduction
This video is adapted from 10.3390/cells12141831
In allogeneic hematopoietic stem cell transplantation (HSCT), Anti-T-Lymphocyte Globulin (ATLG) may be used for the prevention of severe graft-versus-host disease (GVHD). ATLG targets both the recipient’s lymphocytes and those transferred with the graft. Assuming an inverse relation between the recipient’s absolute lymphocyte count (ALC) and exposure of remaining ATLG to the graft, the aim is to evaluate the impact of the recipient’s ALC before the first ATLG administration on the benefits (prevention of GVHD and GVHD-associated mortality) and potential risks (increased relapse incidence) associated with ATLG.
Full Transcript
${ textCharacter }/${ maxCharacter }
Submit
Cancel
Back
Comments
${ item }
|
${ item.createdUser.fullName }
${ item.createdAt }
${ item.vote }
${ item.reply }
Delete
${ reply.createdUser.fullName }
${ reply.createdAt }
${ reply.vote }
Delete
There is no reply to this comment~
${ item.replyTextCharacter }/${ item.replyMaxCharacter }
Submit
Cancel
More
No more~
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes
No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Nikoloudis, A.; Buxhofer-Ausch, V.; Aichinger, C.; Binder, M.; Hasengruber, P.; Kaynak, E.; Wipplinger, D.; Milanov, R.; Strassl, I.; Stiefel, O.; et al. Pre-Treatment Lymphocyte Count Influences ATLG Transplantation Outcomes. Encyclopedia. Available online: https://encyclopedia.pub/video/video_detail/853 (accessed on 18 January 2026).
Nikoloudis A, Buxhofer-Ausch V, Aichinger C, Binder M, Hasengruber P, Kaynak E, et al. Pre-Treatment Lymphocyte Count Influences ATLG Transplantation Outcomes. Encyclopedia. Available at: https://encyclopedia.pub/video/video_detail/853. Accessed January 18, 2026.
Nikoloudis, Alexander, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber, Emine Kaynak, Dagmar Wipplinger, Robert Milanov, Irene Strassl, Olga Stiefel, et al. "Pre-Treatment Lymphocyte Count Influences ATLG Transplantation Outcomes" Encyclopedia, https://encyclopedia.pub/video/video_detail/853 (accessed January 18, 2026).
Nikoloudis, A., Buxhofer-Ausch, V., Aichinger, C., Binder, M., Hasengruber, P., Kaynak, E., Wipplinger, D., Milanov, R., Strassl, I., Stiefel, O., Machherndl-Spandl, S., Petzer, A., Weltermann, A., & Clausen, J. (2023, August 10). Pre-Treatment Lymphocyte Count Influences ATLG Transplantation Outcomes. In Encyclopedia. https://encyclopedia.pub/video/video_detail/853
Nikoloudis, Alexander, et al. "Pre-Treatment Lymphocyte Count Influences ATLG Transplantation Outcomes." Encyclopedia. Web. 10 August, 2023.
Copy Citation